Published in Asian J Androl on December 20, 2007
Constitutively active AR-V7 plays an essential role in the development and progression of castration-resistant prostate cancer. Sci Rep (2015) 1.30
The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl (2011) 1.09
Recent advances in bone-targeted therapies of metastatic prostate cancer. Cancer Treat Rev (2014) 0.97
Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients. Asian J Androl (2009) 0.96
Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Asian J Androl (2012) 0.89
miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth. Asian J Androl (2013) 0.85
Serum early prostate cancer antigen (EPCA) level and its association with disease progression in prostate cancer in a Chinese population. PLoS One (2011) 0.78
Retrospective descriptive analysis of the physiological kinetics of prostate-specific antigen in men older than 75 years. Asian J Androl (2009) 0.76
Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate (2010) 1.81
External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma. J Urol (2012) 1.58
Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J Urol (2010) 1.49
Defining good candidates for extraperitoneal cystectomy: results from random peritoneum biopsies of 136 cases. Urology (2013) 1.45
Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib. Int J Urol (2011) 1.44
A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. Prostate (2010) 1.11
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort. Asian J Androl (2012) 1.05
New N staging system of penile cancer provides a better reflection of prognosis. J Urol (2011) 0.99
Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. J Urol (2012) 0.97
Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients. Asian J Androl (2009) 0.96
Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer. Cancer Sci (2014) 0.95
Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urol Oncol (2010) 0.92
c-KIT: potential predictive factor for the efficacy of sorafenib in metastatic renal cell carcinoma with sarcomatoid feature. Clin Genitourin Cancer (2012) 0.92
An elevated serum miR-141 level in patients with bone-metastatic prostate cancer is correlated with more bone lesions. Asian J Androl (2013) 0.92
Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int (2009) 0.90
Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer. Tumour Biol (2014) 0.90
Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Asian J Androl (2012) 0.89
Primary yolk sac tumor of seminal vesicle: a case report and literature review. World J Surg Oncol (2012) 0.89
Prospectively packaged ilioinguinal lymphadenectomy for penile cancer: the disseminative pattern of lymph node metastasis. J Urol (2009) 0.89
Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries. Asian J Androl (2008) 0.86
Validation of the prognostic value of lymph node ratio in patients with penile squamous cell carcinoma: a population-based study. Int Urol Nephrol (2013) 0.86
Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a "second look" matters? Int Urol Nephrol (2011) 0.85
Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report. Urol Int (2010) 0.85
Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors. PLoS One (2013) 0.85
Lymph node metastases and prognosis in penile cancer. Chin J Cancer Res (2012) 0.85
Penile metastasis from primary bladder cancer: a study of 8 cases and review of the literature. Onkologie (2012) 0.83
Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy. Medicine (Baltimore) (2015) 0.83
A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients. Chin J Cancer (2014) 0.83
Influence of obesity on localized prostate cancer patients treated with radical prostatectomy. Asian J Androl (2013) 0.83
Genitourinary small-cell carcinoma: 11-year treatment experience. Asian J Androl (2014) 0.82
The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer. J Urol (2008) 0.82
Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: a clinicopathological analysis of 56 cases. BJU Int (2014) 0.81
Spiradenocarcinoma, cylindrocarcinoma and spiradenocylindrocarcinoma: a clinicopathological study of nine cases. Histopathology (2014) 0.81
Organ-sparing surgery for penile cancer: complications and outcomes. Urology (2011) 0.81
Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China. BJU Int (2014) 0.81
Population-based assessment of the number of lymph nodes removed in the treatment of penile squamous cell carcinoma. Urol Int (2013) 0.80
Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy. Int Urol Nephrol (2012) 0.80
Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology. Urol Int (2011) 0.80
A nomogram to predict the duration of drainage in patients with penile cancer treated with inguinal lymph node dissection. J Urol (2011) 0.80
The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy? Asian J Androl (2012) 0.79
External validation of nomograms for predicting cancer-specific mortality in penile cancer patients treated with definitive surgery. Chin J Cancer (2014) 0.79
MS4A8B promotes cell proliferation in prostate cancer. Prostate (2014) 0.78
Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China. BJU Int (2014) 0.78
Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences. Hum Pathol (2013) 0.78
Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance. BJU Int (2007) 0.78
Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits proliferation and induces apoptosis in a caspase-dependent manner in human bladder cancer cell lines. Oncol Lett (2013) 0.78
Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: a pilot study. Urol Oncol (2011) 0.77
Human epidermal growth factor receptor type 2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy. Asian J Androl (2008) 0.77
Pelvic floor electrical stimulation for postprostatectomy urinary incontinence: a meta-analysis. Urology (2012) 0.77
Comparison of accuracy among three generations of Partin tables in a Chinese cohort. Can J Urol (2011) 0.77
Extramammary Paget's diseases in men from the Shanghai area: its association with PSA level increase. APMIS (2010) 0.77
Perioperative complications of radical retropubic prostatectomy in patients with locally advanced prostate cancer: a comparison with clinically localized prostate cancer. Asian J Androl (2012) 0.76
Use of RENAL nephrometry scores for predicting tumor upgrading between core biopsies and surgical specimens: a prospective ex vivo study. Medicine (Baltimore) (2015) 0.75
Re: Evaluation of current TNM classification of penile carcinoma: J. A. Leijte, M. Gallee, N. Antonini and S. Horenblas J Urol 2008; 180: 933-938. J Urol (2009) 0.75
Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients. Medicine (Baltimore) (2016) 0.75
Kinetics of testosterone recovery in clinically localized prostate cancer patients treated with radical prostatectomy and subsequent short-term adjuvant androgen deprivation therapy. Asian J Androl (2013) 0.75
Mechanically assisted intra-arterial thrombolysis in acute cerebral infarction. Exp Ther Med (2013) 0.75
Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China. Medicine (Baltimore) (2015) 0.75
The effectiveness of the TAX 327 nomogram in predicting overall survival in Chinese patients with metastatic castration-resistant prostate cancer. Asian J Androl (2013) 0.75
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration. BJU Int (2011) 0.75
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1). Asian J Androl (2015) 0.75
Yolk sac tumor in a patient with transverse testicular ectopia. World J Surg Oncol (2011) 0.75
[Penile rehabilitation with vacuum erection device for erectile dysfunction after radical prostatectomy]. Zhonghua Nan Ke Xue (2012) 0.75
ADAM9 decreases in castration resistant prostate cancer and is a prognostic factor for overall survival. Chin Med J (Engl) (2012) 0.75
Repeat dynamic sentinel node biopsy in locally recurrent penile carcinoma. BJU Int (2010) 0.75
Comparison of three versions of Partin tables to predict final pathologic stage in a Chinese cohort: a decision curve analysis. Urol Int (2013) 0.75
[The survival analysis of metastatic prostate cancer]. Zhonghua Wai Ke Za Zhi (2010) 0.75